SRC and neuroblastoma: Data from the R2: Genomics Analysis and Visualization Platform (http://r2.amc.nl) databases confirm that FGFR1 (Fig. 4c, d) and Src (Fig. 4e, f) are unfavourable prognostic markers for pancreatic cancer adenocarcinoma and human neuroblastoma.